COVID-19 Updates: Get the latest information from our experts: Vaccines Testing Visitor & Mask Guidelines Closings

gradient background

Grants and Funding

Center For Infectious Diseases and Immunology

Center for Infectious Disease and Immunology image

Microbiology and Molecular Biology of AOM caused by Pneumococci .PI: Michael E. Pichichero, MD. Investigator-Initiated Research Agreement Pfizer Vaccine Research. 05/01/09 – 12/31/15.

Phase 4, Post marketing Study Evaluating the Impact of Prevnar 13 (13-Valent Pneumococcal Conjugate Vaccine, 13vPnC) in Reducing Acute Otitis Media and Nasopharyngeal Colonization Caused by vaccine Serotypes of Streptococcus pneumoniae in Healthy Children. PI: Michael E. Pichichero, MD- Sponsor Pfizer Vaccine Research. 10/1/10-12/31/15

Infant Mouse Models of Pneumococcal Colonization and Pneumonia, seeking a correlate of protection. PI: Michael E. Pichichero, MD- Sponsor: Sanofi Pasteur. 1/1/11-12/31/13.

NTHi Immunity in Young Children. PI: Michael E, Pichichero, MD. NIH, NIDCD, RO-1008671, 3/1/12-2/28/17

Pneumococcal protein recombinant vaccine (PPrV) correlates of protection.. PI: Michael E. Pichichero, MD. Sponsor: Sanofi Pasteur. 1/1/13-12/31/16.

Immune Potentiation to Improve Neonatal and Pediatric Vaccines. PI: Naveen Surendran, Michael Pichichero MD. NIH, R03 AI117700. 5/1/15-4/30/17.

Immunogenicity of Moraxella catarrhalis vaccine candidates in children. PI: Dabin Ren, Michael E Pichichero MD. NIH, R03 AI113649. 5/4/15-6/30/17.

Determinants of Streptococcus pneumoniae (Spn) pathogenesis during viral co-infections: comparative studies in infant and adult mice. PI: M. Nadeem Khan. Sponsor: Merck. 10/1/15-9/30/16.

Evaluation of PCV15 vaccine efficacy against Streptococcus pneumonia nasopharyngeal commensal carriage and invasive spn pathogenesis in adult and infant mice. PI: M. Nadeem Khan. Sponsor: Merck. 10/1/16-9/30/17.

Identification of protective epitopes of Streptococcus pneumoniae protein vaccine candidates against pneumococcal diseases. PI: Qingfu Xu. Sponsor: Merck. 11/23/15-11/22/16.

Comparative analysis of inflammatory responses and bacterial virulence gene expressions induced by non-pathogenic and pathogenic strains of Streptococcus pneumonia stereotype 22F causing acute otitis media. PI: Qingfu Xu. Sponsor: Merck. 11/23/16-11/22/17.

A Study Evaluating Acute Otitis Media and Nasopharyngeal Colonization caused by Streptococcus pneumonia in Healthy Children. PI: Michael E. Pichichero, MD (Investigator-Initiated). Sponsor: Sanofi Pasteur 1/1/15-6/30/19. Molecular Analysis of Pathogens in Otitis Media by PCR. PI: Ravinder Kaur. Sponsor: Drexel University. 01/01/16-03/31/18. Microbiome and Virome of Children. PI: Michael E. Pichichero, MD. (Investigator-Initiated). Sponsor: Merck. 12/1/18-12/31/19.

Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A (PCV15 components) that correlate with protection from acute otitis media in children. CI: Michael E Pichichero: Merck. 11/2018-10/2019

191. Protective levels of anti-pneumococcal polysaccharide 22F and 33F antibodies induced by PCV15 in murine models on invasive and non-invasive pneumococcal disease. CI: Michael E. Pichichero. Sponsor Merck. 11/2018-10/2019

Assessing effect of PCV13 use on incidence of antibiotic-resistant pathogens causing otitis media in children using routine tympanocentesis in outpatient primary care pediatrics. PI: Michael E. Pichichero. Sponsor CDC. 9/30/19-9/29/20